r/valueinvesting
UHS（Universal Health Services）是一只便宜的成长型现金牛吗？
UHS 是一只便宜的现金牛，EPS 增长强劲且有回购，尽管近期因收购、政策变化和利率风险而下跌。
- EPS 从 2019 年的 9.16 美元大幅增长至 2025 年的 23.42 美元，得益于大规模的股票回购计划。
- 受益于强劲的人口结构顺风，包括人口老龄化以及德州和佛州等关键州的人口增长。
- 目前股价在 52 周低点附近徘徊，距离去年 12 月的高点有 74.5% 的潜在上涨空间。
- 近 10 亿美元收购 TalkSpace 带来了整合方面的不确定性。
- 容易受到监管逆风的影响，包括 Medicare/Medicaid 政策变化以及潜在的诉讼赔偿。
- 由于公司庞大的债务负担，利率上升可能会压缩利润率。
UHS 是一家财富500强企业，拥有超过300家医疗设施、医院以及心理健康类机构（涵盖精神健康、药物滥用、精神分裂症等治疗）遍布美国和英国...
该公司在过去五年中显著提升了收入和盈利水平，盈利增长了50%……过去六年的每股收益从2019年的9.16美元飙升至2025年的23.42美元。这一增长得益于公司大规模的股票回购计划，本质上是对自己未来增长的押注。
UHS的资产负债表在近期保持稳定，尽管过去五年债务从45.6亿美元增至51.7亿美元，但考虑到公司EPS和收入的惊人增长，这种债务上升是可以预期的。公司目前仍持有1亿至1.5亿美元的现金储备。
该公司面临多个强劲的利好因素：美国人口老龄化将带来对更多医疗设施的需求；慢性病患病率持续上升。此外，公司在多个预计人口增长迅速、需求旺盛的地区拥有大量设施，如德克萨斯州、佛罗里达州、加利福尼亚州和内华达州，尽管其业务覆盖全国。
目前UHS股价正徘徊在其52周低位附近，若回升至去年12月的历史高点，理论上存在约74.5%的上涨空间，距离当前时间不足7个月。
为什么2026年股价会大幅下跌？原因有几点……收购TalkSpace耗资近10亿美元，带来了不确定性；Medicare和Medicaid政策的变化，这两项医保项目贡献了UHS相当大比例的收入；其他监管变动，例如2025年7月4日出台的新规——“将工作与社区服务要求附加于获得医疗补助资格的条件”；潜在的利率上升风险，公司持有部分债务（为实现快速扩张），若利率上升，利息支出将增加，压缩利润空间；以及即将开庭的诉讼案件结果，可能迫使UHS支付赔偿金，这几乎是整个医疗行业都必须面对的问题。
回顾公司的风险因素，我认为其中大多数（在我看来）属于短期问题，不太可能影响公司的长期盈利能力。
该公司提供股息，多年来一直维持每股0.20美元的派息水平，在当前股价下年收益率仅为0.57%。公司更侧重于股票回购，2019年至2025年间回购比例在4%至11%之间波动，此举直接推升每股收益，也是对公司自身前景的信心体现。公司内部人士持股比例超过16%，显示出管理层对股东回报的高度关注。
UHS是一个极佳的对冲科技板块和‘AI泡沫’的标的，依然具备高增长潜力、卓越的股票回购力度，以及稳定的分红，现价处于52周低点，距离此前高点仅需7个月便有望实现75%的反弹空间。
不构成投资建议。
UHS has been dropping hard since February along with other hospital and skilled nursing stocks: (HCA, THC, ENSG). During this exact same time period health insurance and value based care providers have been ripping: (HUM, UNH, AGL, ALHC).
Yes there was a medicare rate decision in April, but the primary driver for both of these trends is decreased healthcare utilization. HCA, HUM and others touched on this trend in their recent earnings call, but its not just first quarter. Check ALHC's recent presentation at Goldman investor conference. They say utilization in second quarter has been benign. Goldman backs them up and says their internal data indicates the same.
The trend of increased health utilization following the early COVID years (maybe 2023-25) appears to have reversed. I've been long and continue to be long AGL, ALHC, ASTH. And I am avoiding hospitals and skilled nursing for the time being.
Interesting opinion, thanks for the insight. I'm always interested in stocks that drop significiantly in such a short period of time without too much reason for the drop... Especially if they have solid fundamentals. Perhaps this is a 'cold' period for hospitals and skilled nursing could recover as quickly as it has gone 'cold'. In the meantime, it makes the companies buybacks even more affective with a lower share price.
I think that this is probably a one time blip. An aging population is going to drive demand for healthcare.
Eventually but it's going to take a while. Covid reinfections were common until start of 2026 and they cause all kinds of health problems: strokes, heart problems, dementia. Covid wastewater levels have been very low for months now. Dialysis and life insurance back up healthier than expected population narrative: check DVA or GL conference calls and stock prices. They are all reporting lower than expected mortality in 2026. As long as wastewater levels stay low it's bullish for health insurers, dialysis providers and life insurance too. At least for a couple of years until continuously aging population reverses the trend once again.
Hey I'm not an investor but I worked for UHS. They're the closest thing I can think of to an evil company, because they value profits above everything else, including staff and patient safety. I hope this company crumbles. Look it up online, they have a lot of news coverage on this stuff and former staff share stories.